Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Recommendation of "Moderate Buy" by Analysts

Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) has received an average rating of "Moderate Buy" from the eleven analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $81.10.

Several equities research analysts have recently weighed in on the stock. Wells Fargo & Company began coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Mizuho began coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 target price for the company. UBS Group decreased their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Barrington Research reissued an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research report on Wednesday, February 26th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th.

Henry Schein Stock Up 1.6 %

Shares of HSIC traded up $1.15 during mid-day trading on Friday, hitting $71.46. The company's stock had a trading volume of 2,532,278 shares, compared to its average volume of 1,479,525. The company's 50-day moving average is $74.42 and its 200-day moving average is $72.51. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.49. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of 29.41, a PEG ratio of 2.13 and a beta of 0.91. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. During the same period in the previous year, the company posted $0.66 EPS. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the stock. Versant Capital Management Inc increased its stake in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after acquiring an additional 335 shares during the period. Investment Management Corp VA ADV acquired a new stake in shares of Henry Schein in the fourth quarter worth $32,000. Venturi Wealth Management LLC increased its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after acquiring an additional 569 shares during the period. Quent Capital LLC increased its stake in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after acquiring an additional 323 shares during the period. Finally, Smartleaf Asset Management LLC grew its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after buying an additional 143 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.